You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,555,877


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,555,877
Title:Nasal delivery device
Abstract: A delivery device (20, 22) for and a method of delivering a substance to the nasal airway (1) of a subject, in particular the posterior region of the nasal airway, the delivery device comprising: a closure unit for causing the closure of the oropharyngeal velum of the subject; and a delivery unit for delivering a gas flow entraining a substance to one of the nostrils of the subject at such a driving pressure as to flow around the posterior margin of the nasal septum and out of the other nostril of the subject, wherein the delivery unit comprises a nosepiece (30, 40, 58, 82, 102, 132) which includes an outlet through which the gas flow is in use delivered to the one nostril and a sealing member for sealing the one nostril to the outlet such as in use to prevent the escape of the gas flow through the one nostril.
Inventor(s): Djupesland; Per Gisle (Oslo, NO)
Assignee: OptiNose AS (Oslo, NO)
Application Number:11/445,812
Patent Claim Types:
see list of patent claims
Delivery; Device;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 8,555,877

To delve into the details of the scope and claims of United States Patent 8,555,877, it is essential to follow a structured approach that includes understanding the patent's background, its claims, the patent landscape, and any relevant legal and procedural aspects.

Background of the Patent

United States Patent 8,555,877, like any other patent, is a grant of rights for an invention, issued by the U.S. Patent and Trademark Office (USPTO). The patent typically includes a detailed description of the invention, drawings, and claims that define the scope of the invention[2].

Claims of the Patent

The claims section of a patent is crucial as it defines the legal boundaries of the invention. Claims are statements that describe the invention in a way that distinguishes it from prior art. There are two main types of claims: independent claims and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit an independent claim[3].

Independent Claims

Independent claims in a patent like 8,555,877 would typically describe the broadest aspects of the invention. For example, if the patent is for a new medical device, an independent claim might describe the overall structure and function of the device.

Dependent Claims

Dependent claims build upon the independent claims by adding additional features or limitations. These claims help to narrow down the scope of the invention and can provide additional protection against infringement.

Patent Landscape

The patent landscape refers to the collection of patents and patent applications related to a particular technology or field. Understanding this landscape is crucial for identifying potential competitors, assessing the novelty of an invention, and navigating the intellectual property landscape.

Prior Art Search

Conducting a prior art search using tools like the USPTO's Patent Public Search or international databases such as the European Patent Office's esp@cenet can help identify existing patents and applications that may be relevant to the invention described in 8,555,877[4].

Global Dossier

The Global Dossier service provided by the USPTO allows users to view the file histories of related applications from participating IP offices. This can be particularly useful in understanding the global patent family and any office actions related to the patent[4].

Legal and Procedural Aspects

Obviousness-Type Double Patenting (ODP)

In cases where multiple patents are derived from the same application or have overlapping subject matter, the issue of obviousness-type double patenting (ODP) may arise. The USPTO and courts have established that ODP analyses must consider the adjusted expiration date of the patent, including any Patent Term Adjustment (PTA)[1].

Patent Term Adjustment (PTA)

PTA is granted for delays during the prosecution process. However, as seen in the case of In re Cellect LLC, the grant of PTA does not extend the term of a patent past the date of a terminal disclaimer. This is crucial for determining the actual expiration date of a patent and its implications for ODP analyses[1].

Terminal Disclaimers

Terminal disclaimers are often used to overcome ODP rejections. These disclaimers ensure that the later-expiring patent does not extend beyond the expiration date of the earlier patent, thereby preventing an inventor from securing a second, later-expiring patent for the same invention[1].

Ex Parte Reexamination

In cases where the validity of a patent is challenged, ex parte reexamination may be requested. However, such requests must present a substantial new question of patentability, which was a point of contention in the In re Cellect LLC case[1].

Economic and Strategic Implications

Patent Scope and Economic Impact

The scope of a patent, as defined by its claims, can significantly impact its economic value. Broader claims may provide greater protection but also increase the risk of infringement lawsuits. Narrower claims may offer less protection but reduce the risk of litigation. The USPTO's Patent Claims Research Dataset can provide insights into the scope and economic impact of patents[3].

Strategic Patent Management

Understanding the patent landscape and the scope of claims is essential for strategic patent management. This includes identifying potential licensing opportunities, assessing the risk of infringement, and making informed decisions about patent enforcement and defense.

Key Takeaways

  • Claims Definition: The claims section of a patent is critical and defines the legal boundaries of the invention.
  • Patent Landscape: Understanding the patent landscape helps in identifying competitors and navigating intellectual property.
  • Legal Considerations: ODP, PTA, and terminal disclaimers are important legal aspects to consider when analyzing a patent.
  • Economic Impact: The scope of a patent can significantly affect its economic value and strategic management.

Frequently Asked Questions (FAQs)

What is the significance of independent and dependent claims in a patent?

Independent claims define the broadest aspects of the invention, while dependent claims add additional features or limitations to narrow down the scope.

How does the USPTO's Global Dossier service help in patent research?

The Global Dossier service allows users to view the file histories of related applications from participating IP offices, providing a comprehensive view of the global patent family.

What is the impact of Patent Term Adjustment (PTA) on the expiration date of a patent?

PTA does not extend the term of a patent past the date of a terminal disclaimer, and any ODP analysis must consider the adjusted expiration date.

What is the purpose of a terminal disclaimer in patent law?

A terminal disclaimer ensures that a later-expiring patent does not extend beyond the expiration date of an earlier patent, preventing an inventor from securing a second, later-expiring patent for the same invention.

How can the USPTO's Patent Claims Research Dataset be useful for analyzing patents?

The dataset provides detailed information on claims from U.S. patents and applications, helping in understanding the scope and economic impact of patents.

Cited Sources:

  1. In re Cellect, LLC, United States Court of Appeals for the Federal Circuit, August 28, 2023.
  2. U.S. Patent and Trademark Office (USPTO), USA.gov.
  3. Patent Claims Research Dataset, USPTO.
  4. Search for patents, USPTO.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,555,877

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,555,877

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9904906.6Mar 3, 1999
United Kingdom9911686.5May 19, 1999

International Family Members for US Patent 8,555,877

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 285810 ⤷  Subscribe
Austria 422923 ⤷  Subscribe
Austria 427130 ⤷  Subscribe
Austria 487506 ⤷  Subscribe
Austria 506983 ⤷  Subscribe
Austria 514445 ⤷  Subscribe
Australia 2002255224 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.